Related references
Note: Only part of the references are listed.A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer
M. E. McDowell et al.
EUROPEAN JOURNAL OF CANCER CARE (2009)
The Vitamin D Receptor Agonist Elocalcitol Inhibits IL-8-Dependent Benign Prostatic Hyperplasia Stromal Cell Proliferation and Inflammatory Response by Targeting the RhoA/Rho Kinase and NF-κB Pathways
Giuseppe Penna et al.
PROSTATE (2009)
Inflammation in Benign Prostatic Hyperplasia: A 282 Patients' Immunohistochemical Analysis
Gregoire Robert et al.
PROSTATE (2009)
BPH progression: Concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE
Claus G. Roehrborn
BJU INTERNATIONAL (2008)
Inflammation and benign prostatic hyperplasia
J. Curtis Nickel
UROLOGIC CLINICS OF NORTH AMERICA (2008)
Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: A prospective, randomized, double-blind, placebo-controlled study
Siavash Falahatkar et al.
UROLOGY (2008)
Examination of the relationship between symptoms of prostatitis and histological inflammation: Baseline data from the REDUCE chemoprevention trial
J. Curtis Nickel et al.
JOURNAL OF UROLOGY (2007)
Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?
Vibhash C. Mishra et al.
BJU INTERNATIONAL (2007)
Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol
Giuseppe Penna et al.
JOURNAL OF IMMUNOLOGY (2006)
Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium
WZ Wang et al.
PROSTATE (2004)
Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate
GE Steiner et al.
PROSTATE (2003)
Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis
F Di Silverio et al.
EUROPEAN UROLOGY (2003)
BPH and inflammation: Pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay
RV Navarrete et al.
EUROPEAN UROLOGY (2003)
Chronic prostatitis - an infectious disease?
KG Naber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
